Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723598 | SCV000114382 | uncertain significance | not provided | 2013-03-12 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000152361 | SCV000201281 | uncertain significance | not specified | 2013-05-03 | criteria provided, single submitter | clinical testing | The 32246-8A>G variant in TTN has not been reported in individuals with cardiomy opathy, but has been identified in 3/3650 African American chromosomes by the NH LBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pa thogenicity. Additional studies are needed to fully assess its clinical signifi cance. |
Gene |
RCV000723598 | SCV000715467 | likely benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089077 | SCV001007191 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-11-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152361 | SCV002041813 | uncertain significance | not specified | 2021-11-15 | criteria provided, single submitter | clinical testing |